Higher medical insurance premiums have triggered outrage and debate about healthcare costs in Malaysia. The government has rolled out interim measures, but experts say broader reforms and greater ...
Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...
Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...
Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...
The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 ...
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
Bladder cancer treatment continues to evolve, incorporating groundbreaking techniques to enhance survival rates and minimize side effects. Depending on the stage of the disease, treatment options ...
GlobalData on MSN8d
AstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trialThe treatment regimen reduced the risk of developing distant metastases or death due to bladder cancer by 33%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback